Visual outcomes of photorefractive keratectomy in non-children with anisometropic amblyopia: One-year Follow-up Outcomes

医学 眼科 光折变性角膜切除术 立体视敏度 屈光参差 验光服务 折射误差 视力
作者
Mohammad Etezad-Razavi,Bahar Tafaghodi-Yousefi,Alireza Eslampour,Mohammad Yaser Kiarudi,Marzieh Najjaran,Hamed Momeni‐Moghaddam,Jorge L. Alió
出处
期刊:European Journal of Ophthalmology [SAGE]
卷期号:32 (5): 2615-2621 被引量:1
标识
DOI:10.1177/11206721211073033
摘要

Objective To evaluate the safety, efficiency, short term stability, and sensory results of photorefractive keratectomy (PRK) in anisometropic in non-compliant children with correction. Methods Twelve eyes of 12 children with an age range: 6–17 years and anisometropic amblyopia who underwent PRK under general anesthesia to correct the dioptric difference between the eyes were included in this study. A complete ophthalmic assessment including refractive status, uncorrected and corrected distance visual acuity (UDVA & CDVA), and binocular vision status using the Worth 4-dot test and stereopsis were performed before and 1, 3, 6, and 12 months after PRK. Results The mean preoperative CDVA was 0.34 ± 0.24 LogMAR which showed a statistically significant improvement at 12 months (0.20 ± 0.19, p = 0.024) after surgery compared to the preoperative assessment. (p = 0.003) The mean preoperative UDVA was 0.63 ± 0.24 LogMAR that increased to 0.44 ± 0.24, 0.32 ± 0.16, 0.25 ± 0.19, and 0.25 ± 0.19 LogMAR at 1, 3, 6, and 12 months after PRK, respectively. One to three lines improvement in UDVA and CDVA was seen in 10 (83.4%) and 8 eyes (66.7%); while one line UDVA and CDVA loss was seen in one (8.3%) and one (8.3%) eye and unchanged UDVA and CDVA was seen in 1 (8.3%) and 3 eyes (25%), respectively. The mean preoperative stereoacuity was 341.9 ± 245.7 s of arc, which significantly improved to 166.6 ± 87.5 s of arc 12 months after PRK. (p = 0.012) Conclusion PRK was an effective surgical alternative to improve visual acuity and stereopsis in anisometropic children who did not cooperate with conventional methods of amblyopia therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
仚屳完成签到,获得积分10
刚刚
Naixi完成签到,获得积分10
刚刚
今后应助HU采纳,获得10
刚刚
su完成签到 ,获得积分10
2秒前
平淡的依白完成签到,获得积分20
2秒前
xinchengzhu关注了科研通微信公众号
2秒前
爱静静应助tao采纳,获得10
3秒前
iNk应助Rebekah采纳,获得10
3秒前
HopeStar完成签到,获得积分10
4秒前
树叶有专攻完成签到,获得积分10
4秒前
4秒前
田様应助Mia采纳,获得20
4秒前
所所应助吃点红糖馒头采纳,获得10
4秒前
今后应助PSCs采纳,获得10
4秒前
5秒前
duguqiubai4发布了新的文献求助10
5秒前
独特的沛凝完成签到,获得积分10
7秒前
思源应助淇淇怪怪采纳,获得10
7秒前
领导范儿应助徐慕源采纳,获得10
7秒前
听粥完成签到,获得积分10
8秒前
高高迎蓉完成签到,获得积分10
8秒前
豆花完成签到,获得积分10
8秒前
SYLH应助风趣的无剑采纳,获得10
8秒前
悲伤水凝胶完成签到,获得积分10
8秒前
鲸鱼完成签到,获得积分10
10秒前
huangqinxue完成签到,获得积分10
10秒前
11秒前
11秒前
Tina完成签到,获得积分10
11秒前
电催化皮皮完成签到,获得积分10
11秒前
大模型应助阿蒙采纳,获得10
12秒前
duguqiubai4完成签到,获得积分10
12秒前
13秒前
meta完成签到,获得积分10
13秒前
大饼完成签到,获得积分10
14秒前
爆米花应助WJM采纳,获得10
14秒前
xiexuqin完成签到,获得积分10
14秒前
14秒前
silentJeremy发布了新的文献求助200
15秒前
JonyiCheng完成签到,获得积分10
15秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527469
求助须知:如何正确求助?哪些是违规求助? 3107497
关于积分的说明 9285892
捐赠科研通 2805298
什么是DOI,文献DOI怎么找? 1539865
邀请新用户注册赠送积分活动 716714
科研通“疑难数据库(出版商)”最低求助积分说明 709678